Top News

Important funding and news from NIH.

• Coronavirus Disease 2019 (COVID-19) information for NIH grant applicants and grant recipients from the NIH Office of Extramural Research (OER)
  Related Notices from NIH, FDA and AHRQ:
  • Notices of participation in PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) from:
    National Cancer Institute (NCI) (NOT-CA-20-048)
    National Institute on Deafness and Other Communication Disorders (NIDCD) NOT-DC-20-003)
    National Human Genome Research Institute (NHGRI) (NOT-HG-20-034)
    National Institute on Minority Health and Health Disparities (NIMHD) (NOT-MD-20-018)
    National Center for Advancing Translational Sciences (NCATS) (NOT-TR-20-015)
  • Notices of Special Interest: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
    National Institute on Aging (NIA) (NOT-AG-20-022)
    National Human Genome Research Institute (NOT-HG-20-030)
  • Updates on NIAID funding for SARS-CoV-2 and COVID-2019 research
    NIAID Funding News, Apr 1, 2020
  • Coronavirus news, funding and resources for global health researchers from Fogarty

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

• Notice of Special Interest from the National Institute of Mental Health (NIMH):
  Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets (NOT-MH-20-024)
  Mental Health Comorbidities in HIV Prevention and Treatment (NOT-MH-20-013)
  Strengthening the HIV Prevention Continuum (NOT-MH-20-019)
  Strengthening the HIV Care Continuum (NOT-MH-20-023)
  Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (NOT-MH-20-035)
  Submit applications using one of the listed opportunity announcements or any reissues of the announcement, including the following Fogarty program announcements:
  Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-19-051)
  Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-19-098)
  Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) (PAR-19-283)
  This notice applies to due dates on or after May 7, 2020 and subsequent receipt dates through May 8, 2023.
• Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed (RFA-FD-20-034) from the Food and Drug Administration (FDA) provides funds for the exploration of scientific methods related to understanding the geospatial link between foodborne pathogens in environmental water sources and to food safety. Through projects, studies and information-sharing, the grantee will help increase scientific understanding of the biophysical and socioeconomic relationships between land and water resources at the landscape scale, and will provide international policy guidance aimed at achieving greater management coherence among sectors and across the full global community.
  Application Receipt Date(s): June 1, 2020

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

• Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (PAR-20-158)
  Application Receipt Date(s): July 28, 2020; July 28, 2021; July 28, 2022
• Tuberculosis Research Units (U19 Clinical Trial Optional) (RFA-AI-20-020)
  Application Receipt Date(s): September 28, 2020
• Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) (PAR-20-156)
  Application Receipt Date(s): Standard dates apply.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (PAR-20-157) and (R21 Clinical Trial Optional) (PAR-20-159)
  Application Receipt Date(s): Standard dates apply.
• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) (PAR-20-155)
  Application Receipt Date(s): Standard dates apply.

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

• Notice of Specialist Interest (NOSI): Availability of Funds for Competitive Revision Applications to Conduct Research with a Focus in Chronic Disease and the Reduction of Health Disparities Within the Mission of NIDDK (R01, U01, U24, P30, U54) (NOT-DK-20-012)

Featured Fogarty News and Information

• Profiles of Fogarty Fellows and Scholars, early-stage investigators working on collaborative, mentored research projects in low- and middle-income countries

• View all Fogarty news

• View and subscribe to Fogarty's Global Health Matters e-newsletter